期刊文献+

磁敏感血管征在急性脑梗死诊疗中的临床应用 被引量:2

Clinical Application of Susceptibility Vessel Sign in Diagnosis and Treatment of Acute Cerebral Infarction
下载PDF
导出
摘要 磁敏感加权成像(SWI)是近年来逐渐发展并应用于临床的一项新的磁共振序列,SWI主要利用组织之间磁敏感性的不同形成图像对比。血红蛋白的代谢产物为体内常见的磁敏感物质,在急性脑梗死中,责任动脉内的血栓中含有大量的脱氧血红蛋白,而脱氧血红蛋白作为顺磁性物质可在SWI中表现为直径超过对侧血管的低信号影,这一影像学征象被称为磁敏感血管征(SVS)。SVS除了可用于对急性脑梗死责任动脉内血栓的诊断外,还可进一步分析卒中亚型,评估病情严重程度及临床预后,从而对急性脑梗死治疗方案的选择提供相关的参考信息。 Magnetic susceptibility weighted imaging(SWI)has been developing increasingly in recent years,as a new magnetic resonance sequence.SWI forms a new source of contrast in magnetic resonance,because of the magnetic susceptibility differences of various compounds.The metabolites of hemoglobin are common magnetic susceptible substances in body.In acute cerebral infarction,the thrombus in the responsible artery contains a large amount of deoxyhemoglobin.As a paramagnetic substance,deoxyhemoglobin can present in SWI as a low-signal image with a diameter larger than that of the contralateral vessels,and this imaging sign is called susceptibility vessel sign(SVS).SVS can be used to detect intra-arterial thrombus in acute cerebral infarction.Besides,SVS may also be associated with stroke subtype,extent of infarct and prognosis,so as to provide some reference information for the treatment of cerebral infarction.
作者 孙植培 钱伟东 SUN Zhipei;QIAN Weidong(Department of Neurology,The First Affiliated Hospital of Bengbu Medical College,Bengbu 233000,China)
出处 《医学综述》 2020年第3期544-548,共5页 Medical Recapitulate
基金 蚌埠医学院研究生科研创新计划资助项目(Byycxz1831)
关键词 急性脑梗死 磁敏感血管征 磁敏感加权成像 Acute cerebral infarction Susceptibility vessel sign Magnetic susceptibility weighted imaging
  • 相关文献

参考文献8

二级参考文献84

  • 1Kopecky SL,Gersh BJ,McGoon MD, et al. Lone Atrial Fibrillation in Elderly Persons : A Marker for Cardiovascular Risk[J]. Arch Intern Med (S0003- 9926), 1999,159 : 1118-1122.
  • 2Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria:Incidence,Recurrence,and Long-term Survival in Ischemic Stroke Subtypes: A Population- based Study[J].Stroke (S0039 - 2499), 2001, 32: 2735-2740.
  • 3Pearce LA, Hart RG, Halperin JL. Assessment of Three Schemes for Stratifying Stroke Risk in Patients With Nonvalvular Atrial Fibrillation[J]. Am J Med ( S0002 - 9343), 2000,109 : 45 - 51.
  • 4Wolf PA, Abbott RD,Kannel WB. Atrial Fibrillation: A Major Contributor to Stroke in the Elderly[J]. Arch Intern Med( S0003- 9926), 1987,147 : 1561 - 1564.
  • 5Wolf PA, Abbott RD, Kannel WB. Atrial Fibrillation as an Independent Risk Factor for Stroke:The Framingham Study [J].Stroke ( S0039 - 2499 ), 1991,22 : 983-988.
  • 6Hankey GJ ,Warlow CP. Treatment and Secondary Prevention of Stroke : Evidence, Costs, and Effects on Individuals and Populations [J]. Lancet (S0140 - 6736), 1999,354 : 1457-1463.
  • 7Carswell JL, Beard KA, Chevrette MM, et al. Tracking Trends in Secondary Stroke Prevention Strategies[J]. Ann Pharmacother( S1060 - 0280), 2004,38 : 215 - 219.
  • 8[1]Larry B. Goldstein, Robert Adams, et al. Primary Prevention of Ischemic Stroke :A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Stroke ,2001,32:280-99
  • 9[3]Robert G, Hart MD, Santiago Palacio, MD, Lesly A. Pearce, MS. Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials. Stroke,2002,33:2722-27
  • 10[4]Yamaguchi T.Optimal intensity of warfarin therapt for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. Stroke,2000, 31: 817-21

共引文献66

同被引文献28

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部